Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Johnson

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Blood|March 6, 2002
Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemiaGerard Tobin, Ulf Thunberg, Anna Johnson, et al.
American Journal of Obstetrics & Gynecology MFM|December 1, 2022
Opening Pandora's box: abnormal genetic carrier screening and need for lifetime follow-upTirtza Spiegel Strauss, Emily Boniferro, Erika Brockhoff, et al.
BJU International|May 15, 2025
What is lost in an average? Identifying distinct post-radical prostatectomy functional recovery profilesPatrick Lewicki, Kevin Ginsburg, Nnenaya Mmonu, et al.
Urology|February 10, 2022
Perspectives on the Role of Biopsy for Management of T1 Renal Masses: Survey Results From Two Regional Quality Improvement CollaborativesZachary J Prebay, Amit Patel, Anna Johnson, et al.
European Journal of Haematology|August 2, 2003
Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplantNiels S Andersen, Lone Pedersen, Erkki Elonen, et al.
Blood|February 15, 2003
Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitopeGerard Tobin, Ulf Thunberg, Anna Johnson, et al.
Urologic Oncology|May 4, 2024
Development and validation of a multicenter Cox regression model to predict all-cause mortality in patients with renal masses suspicious for renal cancerBrian R Lane, Joseph G Cheaib, Dennis Boynton, et al.
Urology|September 9, 2021
A Statewide Quality Improvement Collaborative's Adherence to the 2017 American Urological Association Guidelines Regarding Initial Evaluation of Patients With Clinical T1 Renal MassesKevin B Ginsburg, Kyle Johnson, Tudor Moldovan, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 23, 2023
Barriers to completion of expanded carrier screening in an inner city populationTirtza S Strauss, Emily Schneider, Emily Boniferro, et al.
European Journal of Haematology|November 13, 2024
Unveiling the Genetic and Clinical Differences of Acute Myeloid Leukemia (AML) in Obese PatientsFevzi F Yalniz, Anna Johnson, Yanal Alnimer, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Blood|March 6, 2002
Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemiaGerard Tobin, Ulf Thunberg, Anna Johnson, et al.
American Journal of Obstetrics & Gynecology MFM|December 1, 2022
Opening Pandora's box: abnormal genetic carrier screening and need for lifetime follow-upTirtza Spiegel Strauss, Emily Boniferro, Erika Brockhoff, et al.
BJU International|May 15, 2025
What is lost in an average? Identifying distinct post-radical prostatectomy functional recovery profilesPatrick Lewicki, Kevin Ginsburg, Nnenaya Mmonu, et al.
Urology|February 10, 2022
Perspectives on the Role of Biopsy for Management of T1 Renal Masses: Survey Results From Two Regional Quality Improvement CollaborativesZachary J Prebay, Amit Patel, Anna Johnson, et al.
European Journal of Haematology|August 2, 2003
Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplantNiels S Andersen, Lone Pedersen, Erkki Elonen, et al.
Blood|February 15, 2003
Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitopeGerard Tobin, Ulf Thunberg, Anna Johnson, et al.
Urologic Oncology|May 4, 2024
Development and validation of a multicenter Cox regression model to predict all-cause mortality in patients with renal masses suspicious for renal cancerBrian R Lane, Joseph G Cheaib, Dennis Boynton, et al.
Urology|September 9, 2021
A Statewide Quality Improvement Collaborative's Adherence to the 2017 American Urological Association Guidelines Regarding Initial Evaluation of Patients With Clinical T1 Renal MassesKevin B Ginsburg, Kyle Johnson, Tudor Moldovan, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 23, 2023
Barriers to completion of expanded carrier screening in an inner city populationTirtza S Strauss, Emily Schneider, Emily Boniferro, et al.
European Journal of Haematology|November 13, 2024
Unveiling the Genetic and Clinical Differences of Acute Myeloid Leukemia (AML) in Obese PatientsFevzi F Yalniz, Anna Johnson, Yanal Alnimer, et al.
Pageof 10